DRUGS & PHARMA
Biocon plans a unit in Malaysia

Biocon plans a unit in Malaysia

Bangalore: Biocon plans to invest $161 million (Rs 725 crore) in Malaysia by 2014 to establish a biomanufacturing and research and development unit to manufacture high-end biosimilars and biopharmaceuticals. The company... Full Story

Hetero Group acquires 600 acres in Hyderabad from US fund.

Hyderabad-based generic pharmaceutical company Hetero Group has bought around 600 acres of land for over Rs. 350 crore from a US-based fund,... Full Story

Browse All News by Date

China’s Fosun bids to buy India’s Gland Pharma.

Shanghai Fosun Pharmaceutical (Group) Co. Ltd, the Hong Kong-listed company controlled by billionaire Guo Guangchang, said it had submitted a... Full Story

More Top Stories

LATEST HEADLINES FROM MIDDLE EAST AND NORTH AFRICA
OUR OTHER PRODUCTS & SERVICES: Projects Database | Tenders Database | About Us | Contact Us | Terms of Use | Advertise with Us | Privacy Policy | Disclaimer | Feedback

This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2022

Technology Partner  aaRKayeN Solutions